Benzodiazepine prescrbing in the Republic of Srpska: analysis of prescribing patterns in primary health care

Žana M Maksimović; Mladen Stajić; Dragana Lončar-Stojiljković

doi:10.5937/scriptamed50-22426

Žana M Maksimović Dom zdravlja Modriča, Služba hitne medicinske pomoći; Medicinski fakultet Banja Luka, Centar za biomedicinska istraživanja
Mladen Stajić 1. Primary Healthcare Centre, Modriča 2. Centre for Biomedical Research, Faculty of Medicine, University of Banja Luka, Banja Luka
Dragana Lončar-Stojiljković Institute for Cardiovascular Diseases "Dedinje", Belgrade

DOI: https://doi.org/10.5937/scriptamed50-22426

Sažetak

Introduction. Benzodiazepines (BZDs) are very often (in)appropriately prescribed drugs. The aim of this study is to analyse physicians' prescribing patterns for BZD in the Republic of Srpska, and to assess to what extent primary diagnosis determine the dose and the length of use of BZDs.

Methods. A retrospective analysis of the physicians' prescription habits based on the database of Family Medicine Information Systems of the Republic of Srpska, as well as on data from patient’s medical record were performed. Patients’ socio-demographic and clinical characteristics, including the data on the type and dose of BZDs prescribed, were recorded and evaluated.

Results. BZDs were mostly prescribed for anxiety disorders (30.05%), for depressive disorders (17.54%), and for anxiety-depressive disorders (10.86%). A significant amount of BZDs was prescribed for non-psychiatric diagnoses (23.81%). Patients suffering from psychotic disorders were taking the highest dose of BZD and for the longest periods of time (p<0.001). Longer use of BZDs was in women (r=0.04, p<0.001), elderly (r=0.178, p<0.001), single people (r=0.12, p<0.001), those who live in urban areas (r=0.45, p<0.001) and those who were prescribed higher doses (r=0.213, p<0.001).

Conclusion. A significant percentage of patients were using the BZDs for a longer time period than recommended. Strongest positive correlation was found between the dose and the length of use, which implies the addictive potential of BZDs. Since it has been noticed that prolonged use, or abuse is present regardless of the diagnosis, precaution is advised when prescribing BZDs even for acute diseases.

Keywords: benzodiazepines, primary healthcare, analysis of medicine use, rational pharmacotherapy

Biografije autora

Žana M Maksimović, Dom zdravlja Modriča, Služba hitne medicinske pomoći; Medicinski fakultet Banja Luka, Centar za biomedicinska istraživanja

dr med.

Mladen Stajić, 1. Primary Healthcare Centre, Modriča 2. Centre for Biomedical Research, Faculty of Medicine, University of Banja Luka, Banja Luka

dr med.

Reference

Roy-Byrne PP. The GABA-benzodiazepine receptor complex: structure, function, and role in anxiety. J Clin Psychiatry 2005;66 Suppl 2:14-20.

Winkler A, Auer C, Doering BK, Rief W. Drug treatment of primary insomnia: a meta-analysis of polysomographic randomized controled trials. CNS Drugs 2014 Sep;28(9):799-816.

Lindqvist O, Lundquist G, Dickman A, Bükki J, Lunder U, Hagelin CL, et al. Four essential drugs needed for quality care of the dying: a Delphi-study based international expert consensus opinion. J Palliat Med 2013;16(1):38-43.

Benzodiazepine Committee. Benzodiazepines: good practice guidelines for clinicians [Internet]. Dublin: Department of Health and Children; 2002 [cited 2015 Jul 20]. Available from: http://www.drugsandalcohol.ie/5349/

The Royal Australian College of General Practitioners. Prescribing drugs of dependence in general practice, Part B – benzodiazepines [Internet]. Victoria (AU): The Royal Australian College of General Practitioners; 2015 [cited 2017 Aug 8]. Available from: http://www.drugsandalcohol.ie/24380/

Kurko TA, Saastamoinen LK, Tahkapaa S, Tuulio-Henriksson A, Taiminen T, Tiihonen J, et al. Long-term use of benzodiazepines: definitions, prevalence and usage patterns – a systematic review of register-based studies. Eur Psychiatry 2015;30:1037–47.

Lader M. Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol 2014;77:295–301.

Jones JD, Mogali S, Comer SD. Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend 2012;125(1-2):8-18.

Hooft CS, Schoofs MW, Ziere G, Hofman A, Pols HA, Sturkenboom MC, et al. Inappropriate benzodiazepine use in older adults and the risk of fracture. Br J Clin Pharmacol 2008;66:276–82.

Park H, Satoh H, Miki A, Urushihara H, Sawada Y. Medications associated with falls in older people: systematic review of publications from a recent 5-year period. Eur J Clin Pharmacol 2015;71(12):1429-40.

Palmaro A, Dupouy J, Lapeyre-Mestre M. Benzodiazepines and risk of death: Results from two large cohort studies in France and UK. Eur Neuropsychopharmacol 2015;25(10):1566-77.

Zhong G, Wang Y, Zhang Y, Zhao Y. Association between benzodiazepine use and dementia: a meta-analysis. PLoS One 2015 May 27;10(5):e0127836.

Dold M, Li C, Tardy M, Khorsand V, Gillies D, Leucht S. Benzodiazepines for schizophrenia. Cochrane Database Syst Rev 2012 Nov 14;11:CD006391.

Sim F, Sweetman I, Kapur S, Patel MX. Re-examining the role of benzodiazepines in the treatment of schizophrenia: a systematic review. J Psychopharmacol 2015;29(2):212-23.

Benzo.org.uk. The resource site for involuntary benzodiazepine tranquiliser addiction, withdrawal & recovery. Benzodiazepine equivalence table [Internet]. Newcastle upon Type: Benzo.org.uk; 2016 [cited 2019-Apr-10]. Available from: http://www.benzo.org.uk/bzequiv.htm.

WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD System [Internet]. Oslo (NO): WHO Collaborating Centre for Drug Statistics Methodology; 2009 [cited 2019-Apr-10]. Available from: https://www.whocc.no/atc_ddd_index/

Medscape. Benzodiazepine equivalency table [Internet]. New York, NY (USA): Medscape; 2018 Jul 31 [cited 2019-Apr-10]. Available from: http://emedicine.medscape.com/article/2172250-overview

Sonnenberg CM, Bierman E, Deeg D, Comijs H, Tilburg W, Beekman A. Ten-year trends in benzodiazepine use in the Dutch population. Soc Psychiatry Psychiatr Epidemiol 2012;47(2):293-301.

Manthey L, van Veen T, Giltay E, Stoop J, Neven AK, Penninx B, et al. Correlates of inappropriate benzodiazepine use: the Netherlands Study of Depression and Anxiety (NESDA). Br J Clin Pharmacol 2011;71(2):263-72.

Cahir C, Fahey T, Telling M, Teljeur C, Feely J, Bennett K. Potentialy inappropriate prescribing and cost outcomes for older people:a national population study. Br J Clin Pharmacol 2010;69(5):543-52.

Alvarenga JM, Loyola Filho AI, Firmo JOA, Lima-Costa MF, Uchoa E. Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: the Bambuí Health and Aging Study (BHAS). Rev Bras Psiquiatr 2008;30(1):7-11.

Ramadan W, Khoury G, Deeb M, Sheikh-Taka M. Prescription patterns of benzodiazepines in the Lebanese adult population: a cross-sectional study. Neuropsychiatr Dis Treat 2016;12:2299-305.

Olfson M, King M, Schoenbaum M. Benzodiazepine use in the United States. JAMA Psychiatry 2015;72(2):136-42.

Boyd A, Van de Velde S, Pivette M, Ten Have M, Florescu S, O'Neill S, et al; EU-WMH investigators. Gender differences in psychotropic use across Europe: results from a large cross-sectional, population-based study. Eur Psychiatry 2015;30(6):778-88.

Nordfjærn T, Bjerkeset O, Bratberg G, Moylan S, Berk M, Gråwe R. Socio-demographic, lifestyle and psychological predictors of benzodiazepine and z-hypnotic use patterns. Nord J Psychiatry 2014;68(2):107-16.

Cadogan CA, Ryan C, Cahir C, Bradley CP, Bennett K. Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015. Br J Clin Pharmacol 2018;84(6):1354-63.

Maust DT, Lin LA, Blow FC. Benzodiazepine use and misuse among adults in the United States. Psychiatr Serv 2019;70(2):97-106.

Panes A, Pariente A, Bénard-Laribière A, Lassalle R, Dureau-Pournin C, Lorrain S, et al. Use of benzodiazepines and z-drugs not compliant with guidelines and associated factors: a population-based study. Eur Arch Psychiatry Clin Neurosci 2018 Dec 11. doi: 10.1007/s00406-018-0966-3. [Epub ahead of print]

Sundseth AC, Gjelstad S, Straand J, Rosvold EO. General practitioners’ prescriptions of benzodiazepines, Z-hypnotics and opioid analgesics for elderly patients during direct and indirect contacts. A cross-sectional, observational study. Scand J Prim Health Care 2018;36(2):115–22.

Johnson CF, Frei C, Downes N, McTaggart SA, Akram G. Benzodiazepine and z-hypnotic prescribing for older people in primary care: a cross-sectional population-based study. Br J Gen Pract 2016;66(647):e410-5.

Tvete IF, Bjorner T, Skomedal T. Risk factors for excessive benzodiazepine use in a working age population: a nationwide 5-year survey in Norway. Scand J Prim Helath Care 2015;33(4):252-59.

Canham SL.What's loneliness got to do with it? Older women who use benzodiazepines. Australas J Ageing 2015;34(1):E7-E12.

Romans S, Cohen M, Forte T. Rates of depression and anxiety in urban and rural Canada. Soc Psychiatry Psychiatr Epidemiol 2011;46(7):567-75.

Subramaniam M, He VY, Vaingankar JA, Abdin E, Chong SA. Prevalence of and factors related to the use of antidepressants and benzodiazepines: results from the Singapore Mental Health Study. BMC Psychiatry 2013;13:231. doi: 10.1186/1471-244X-13-231.

Tahiri Z, Kellici S, Mone I, Shabani D, Qazimi M, Burazeri G. Prevalence and correlates of inappropriate use of benzodiazepines in Kosovo. Int J Clin Pharm 2017;39(4):669-73.

Liu SJ, Lan Y, Wu L, Yan WS. Profiles of impulsivity in problematic Internet users and cigarette smokers. Front Psychol 2019 Apr 4;10:772. doi: 10.3389/fpsyg.2019.00772.

Choi J-S, Payne TJ, Ma JZ, Li MD. Relationship between personality traits and nicotine dependence in male and female smokers of African-American and European-American samples. Front Psychiatry 2017;8:122. doi: 10.3389/fpsyt.2017.00122.

Sirdifield C, Anthierens S, Creupelandt H, Chipchase SY, Christiaens T, Siriwardena AN. General practitioners’ experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. BMC Fam Pract 2013 Dec 13;14:191. doi: 10.1186/1471-2296-14-191.

Linnet K, Gudmundsson LS, Birgisdottir FG, Sigurdsson EL, Johannsson M, Tomasdottir MO, et al. Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland. BMC Fam Pract. 2016 Jun 6;17:69. doi: 10.1186/s12875-016-0469-0.

Jacob L, Rapp MA, Kostev K. Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis. Ther Adv Psychopharmacol 2017;7(6-7):191-200.

Weiß V, Nau R, Glaeske G, Hummers E, Himmel W. The interplay of context factors in hypnotic and sedative prescription in primary and secondary care-a qualitative study. Eur J Clin Pharmacol 2019;75(1):87-97.

Vicens C, Leiva A, Bejarano F, Sempere E, Rodríguez-Rincón RM, Fiol F, et al. Intervention to reduce benzodiazepine prescriptions in primary care, study protocol of a hybrid type 1 cluster randomised controlled trial: the BENZORED study. BMJ Open 2019 Jan 30;9(1):e022046. doi: 10.1136/bmjopen-2018-022046.